The report highlights obstacles to pharmacy POCT, such as lack of reimbursement, inadequate collaborative practice models, legislative barriers and more.
Xtandi is the first and only androgen receptor signaling inhibitor approved for use with or without a GnRH analog therapy in nonmetastatic castration-sensitive prostate cancer.
Pharmacists at select Rite Aid stores in California, Maryland, New Hampshire, Nevada and Oregon can now prescribe hormonal contraceptives, improving access for women in these states.